本页面由Tiger Trade Technology Pte. Ltd.提供服务

Apellis Pharmaceuticals Inc.

19.86
-0.3000-1.49%
盘后19.860.00000.00%16:55 EST
成交量:288.34万
成交额:5,726.24万
市值:25.39亿
市盈率:115.19
高:20.32
开:20.32
低:19.55
收:20.16
52周最高:30.48
52周最低:16.10
股本:1.28亿
流通股本:7,811.99万
量比:1.52
换手率:3.69%
股息:- -
股息率:- -
每股收益(TTM):0.1724
每股收益(LYR):0.1724
净资产收益率:7.48%
总资产收益率:3.53%
市净率:6.86
市盈率(LYR):115.19

数据加载中...

2023/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/09/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/29

重要事件披露

Form 8-K - Current report
2023/08/22

重要事件披露

Form 8-K - Current report
2023/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/31

重要事件披露

Form 8-K - Current report
2023/07/19

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/07/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/17

重要事件披露

Form 8-K - Current report
2023/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities